Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

Infections, Papillomavirus

Interventions

BIOLOGICAL

MEDI-517 HPV-16/18 VLP AS04 vaccine

IM injection

BIOLOGICAL

MEDI-517 HPV-16/18 VLP vaccine with Al(OH)3

IM injection

BIOLOGICAL

MEDI-517 HPV-16/18 VLP vaccine without adjuvant

IM injection